UBS Group’s Black Diamond Therapeutics BDTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.2M Buy
564,838
+307,205
+119% +$731K ﹤0.01% 5407
2025
Q4
$626K Sell
257,633
-370,783
-59% -$1.31M ﹤0.01% 5947
2025
Q3
$2.38M Buy
628,416
+314,716
+100% +$921K ﹤0.01% 4794
2025
Q2
$778K Buy
313,700
+185,906
+145% +$358K ﹤0.01% 5656
2025
Q1
$198K Buy
127,794
+77,901
+156% +$163K ﹤0.01% 6569
2024
Q4
$107K Buy
49,893
+11,436
+30% +$32.8K ﹤0.01% 6830
2024
Q3
$167K Buy
38,457
+11,923
+45% +$64.9K ﹤0.01% 6011
2024
Q2
$124K Buy
26,534
+22,263
+521% +$120K ﹤0.01% 6025
2024
Q1
$21.7K Buy
4,271
+284
+7% +$1.15K ﹤0.01% 6893
2023
Q4
$11.2K Buy
3,987
+3,741
+1,521% +$8.78K ﹤0.01% 7404
2023
Q3
$706 Sell
246
-8,273
-97% -$30.5K ﹤0.01% 8323
2023
Q2
$43K Buy
+8,519
New +$17.4K ﹤0.01% 6560
2023
Q1
Sell
-3,433
Closed -$6.18K 9607
2022
Q4
$6.18K Sell
3,433
-1,942
-36% -$3.5K ﹤0.01% 9069
2022
Q3
$9K Sell
5,375
-12,224
-69% -$37.7K ﹤0.01% 8560
2022
Q2
$44K Sell
17,599
-3,221
-15% -$7.49K ﹤0.01% 6011
2022
Q1
$58K Sell
20,820
-8,734
-30% -$31.9K ﹤0.01% 6345
2021
Q4
$157K Buy
29,554
+12,733
+76% +$89K ﹤0.01% 5900
2021
Q3
$143K Buy
16,821
+5,454
+48% +$53.9K ﹤0.01% 5571
2021
Q2
$139K Sell
11,367
-31,822
-74% -$629K ﹤0.01% 5622
2021
Q1
$1.05M Buy
+43,189
New +$1.16M ﹤0.01% 4198
2020
Q4
Sell
-197
Closed -$6K 8382
2020
Q3
$6K Sell
197
-4,457
-96% -$136K ﹤0.01% 7204
2020
Q2
$196K Sell
4,654
-2,577
-36% -$94.8K ﹤0.01% 4807
2020
Q1
$180K Buy
+7,231
New +$220K ﹤0.01% 4799

Other funds holding BDTX